Mortality attributable to tobacco: review of different methods

Archives of Public Health

Nabil Tachfouti²  Chantal Raherison³  Majdouline Obtel⁴  Chakib Nejjari¹ 

[1] University of Bordeaux, Bordeaux, France

[2] Laboratory of Epidemiology, Clinical Research and Community Health -Faculty of Medicine, KM: 2.2 Route de Sidi Harazem, Fez, Morocco

[3] Department of Respiratory Diseases, CHU Bordeaux, France

[4] Department of Epidemiology and Disease control, Ministry of Health, Rabat, Morocco

关键词: Modelization;    Mortality;    Attributable risk;    Tobacco;   

Others  :  1070615
DOI  :  10.1186/2049-3258-72-22

 received in 2013-09-13, accepted in 2014-02-23,  发布年份 2014

【 摘 要 】

Background

One of the most important measures for ascertaining the impact of tobacco is the estimation of the mortality attributable to its use. Several indirect methods of quantification are available. The objective of the article is to assess methodologies published and applied in calculating mortality attributable to smoking.

Methods

A review of the literature was made for the period 1998 to 2005, in the electronic databases MEDLINE. Twelve articles were selected for analysis.

Results

The most widely used methods were the prevalence methods, followed by smoking impact ration method. Ezzati and Lopez showed that the general rate of Smoking attributable mortality (SAM) globally was 12% (18% in men). Across countries, attributable fractions of total adult deaths ranged from 8% in Southern Africa, 13.6% in Brazil (18.1% in men) and 25% in Hong Kong (33% in men).

Conclusion

The variations can be attributed to methodological differences and to different estimates of the main tobacco-related illnesses and tobacco prevalence. All methods show limitations of one type or another, yet there is no consensus as to which furnishes the best information.

【 授权许可】

   
2014 Tachfouti et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Lopez AD, Mathers CD, Ezzatti M, Jamison DT, Murray CJL: Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006, 367:1747-1757.
• [2]Boutayeb A, Boutayeb S: The burden of non communicable diseases in developing countries. Int J Equity Health 2005, 4:2. doi:10.1186/1475-9276-4-2
• [3]Slama K: Global perspective on tobacco control. Part I. The global state of the tobacco epidemic. Int J Tuberc Lung Dis 2008, 12(1):3-7.
• [4]Lopez AD, Collishaw NE, Piha TA: Descriptive model of the cigarette epidemic in developed countries. Tob Control 1994, 3(3):242-247.
• [5]Wen CP, Tsai SP, Yen DD: The health impact of cigarette smoking in Taiwan. Asia Pac J Public Health 1994, 7(4):206-213.
• [6]Gaziano TA, Pagidipati N: Scaling up chronic disease prevention interventions in lower- and middle-income countries. Rev Public Health 2013, 34:317-335.
• [7]Scuffham PA: Cost-effectiveness analyses for injury prevention initiatives in low- and middle-income countries. Inj Prev 2008, 14(4):217-219.
• [8]World health Organization: Global status report on non communicable diseases 2010. Genova; 2011.
• [9]Chaloupka FJ, Jha P, Corrao MA, Costa e Silva V, Ross H, Czart C, Yach D: The evidence base for reducing mortality from smoking in low and middle income countries. Geneva: World Health Organization; 2001.
• [10]World Health Organization: WHO Report on the Global Tobacco Epidemic, 2008. The MPOWER Package. 2008. [WHO Library Cataloguing-in-Publication Data Genova]
• [11]Berg M, Jaakkola MS, Woodward A, Peruga A, Prüss-Ustün A: Worldwide burden of disease from exposure to second-hand smoke: a retrospective analysis of data from 192 countries. Lancet 2011, 377:139-146.
• [12]Mathers CD, Loncar D: Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006, 3(11):e442.
• [13]Ezzati M, Henley J, Thun MJ, Lopez AD: Role of smoking in global and regional cardiovascular mortality. Circulation 2005, 112:489-497.
• [14]The lancet: Tobacco killing in low-income and middle-income countries. Lancet 2012, 379(9822):1172. editorial
• [15]Oliveira AF, Valente JG, Leite IC: Aspects of tobacco attributable mortality: systematic review. Rev Saude Publica 2008, 42(2):335-345.
• [16]Doll R, Peto R, Boreham J, Sutherland I: Mortality in relation to smoking: 50 years’ observations on male British doctors. BMJ 2004, 328:1519-1533.
• [17]Leistikow BN, Kabir Z, Connolly GN, Clancy L, Alpert HR: Male tobacco smoke load and non-lung cancer mortality associations in Massachusetts. BMC Cancer 2008, 8:341.
• [18]Preston SH, Glei DA, Wilmoth JR: A new method for estimating smoking-attributable mortality in high-income countries. Int J Epidemiol 2010, 39(2):430-438.
• [19]Brønnum-Hansen H, Juel K: Estimating mortality due to cigarette smoking: two methods, same result. Epidemiol 2000, 11(4):422-426.
• [20]Center of Disease Control (CDC): Smoking-attributable mortality – Kentucky, 1988. MMWR Morb Mortal Wkly Rep 1990, 39(38):680-683.
• [21]Tanuseputro P, Manuel DG, Schultz SE, Johansen H, Mustard CA: Improving population attributable fraction methods: examining smoking-attributable mortality for 87 geographic regions in Canada. Am J Epidemiol 2005, 161(8):787-798.
• [22]Paulo CRP C, Barreto SM, Valéria MA P: Smokingattributable mortality and years of potential life lost in 16 Brazilian capitals, 2003: a prevalence-based study. BMC Public Health 2009, 9:206. doi: 10.1186/1471-2458-9-206
• [23]Ginsberg GM, Elliot R: Laura Rosen Issues in estimating smoking attributable mortality in Israel. Eur J Pub Health 2009, 20(1):113-119.
• [24]Borges M, Gouveia M, Costa J, Dos Santos PL, Paulo S, Vaz CA: The burden of disease attributable to smoking in Portugal. Revista Portuguesa De Pneumologia 2009, 15(6):951-1004.
• [25]Centers of Disease Control and Prevention (CDC): Annual smoking attributable mortality, years of potential life lost, and productivity losses – United States, 1997–2001. MMWR Morb Mortal Wkly Rep 2005, 54(25):625-628.
• [26]Wen CP, Tsai SP, Chen C-J, Cheng TY, Tsai M-C, Levy DT: Smoking attributable mortality for Taiwan and its projection to 2020 under different smoking scenarios. Tob Control 2005, 14(1):i76-i80.
• [27]World Health Organization: International Statistical Classification of Diseases and Related Health Problems - 10th revision, edition 2010. 2011. [WHO Library Cataloguing-in-Publication Data Geneva]
• [28]Rockhill B, Newman B, Weinberg C: Use and misuse of population attributable fractions. Am J Pub Health 1998, 88:15-19.
• [29]Levin ML: The occurrence of lung cancer in man. Acta Un Intern Cancer 1953, 9:531-541.
• [30]Centers for Disease Control: The Surgeon General’s 1989 Report on Reducing the Health Consequences of Smoking: 25 Years of Progress. Maryland: Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 1989.
• [31]Centers for Disease Control and Prevention: The Health: Consequences of Smoking. In Report of the Surgeon General. Atlanta: Office on Smoking and Health; 2004:1-910.
• [32]Shultz JM, Novotny TE, Rice D: Quantifying the disease impact of cigarette smoking with SAMMEC II Software. Public Health Rep 1991, 106:326-333.
• [33]Gajalakshmi V, Peto R, Kanaka TS, Jha P: Smoking and mortality from tuberculosis and other diseases in India: retrospective study of 43000 adult male deaths and 35000 controls. Lancet 2003, 362:507-515.
• [34]Lam TH, Ho SY, Hedley AJ, Mak KH, Peto R: Mortality and smoking in Hong- Kong: case–control study of all adult deaths in 1998. BMJ 2004, 323:361-362.
• [35]Niu SR, Yang GH, Chen ZM, Wang JL, Wang GH, He XZ, Schoepff H, Boreham J, Pan HC, Peto R: Emerging tobacco hazards in China: early mortality results from a prospective study. BMJ 1998, 317:1423-1424.
• [36]Liu BQ, Peto R, Chen ZM, Boreham J, Wu YP, Li JY, Campbell TC, Chen JS: Emerging tobacco hazards in China: 1. Retrospective proportional mortality study of one million deaths. BMJ 1998, 317:1411-1422.
• [37]Sitas F, Urban M, Bradshaw D, Kielkowski D, Bah S, Peto R: Tobacco attributable deaths in South Africa. Tob Control 2004, 13:396-39935.
• [38]Peto R, Lopez A, Boreman J, Thun M, Heath C: Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet 1992, 339:1268-1278.
• [39]Peto R, Lopez A, Boreham J, Thun M, Heath C: Mortality from tobacco in developed countries 1950–2000: Indirect estimates from national vital statisics. Oxford: Oxford Univ. Press; 1994.
• [40]Ezzati M, Lopez AD: Estimates of global mortality attributable to smoking in 2000. Lancet 2003, 362:847-852.
• [41]Ezzati M, Lopez AD: Measuring the accumulated hazards of smoking: global and regional estimates for 2000. Tob Control 2003, 12:79-85.
• [42]Rodríguez R, Pueyos A, Bueno A, Delgado M, Gálvez R: Proporción de la enfermedad atribuible al tabaco en la provincia de Granada. Med Clin 1994, 102:571-574.
• [43]Tanuseputro P, Schultz S, Manuel D: Estimating smoking-attributable mortality. Can J Public Health 2004, 95:132.
• [44]Davis D: Trends in nonsmoking lung cancer. Epidemiology 1993, 4:489-492.
• [45]Sterling TD, Rosenbaum WL, Weinkam JJ: Risk attribution and tobacco-related deaths. Am J Epidemiol 1993, 138:128-139.
• [46]Rogers RG, Hummer RA, Krueger PA, Pampel FC: Combining prevalence and mortality risk rates: the case of cigarette smoking. In Research program on population processes. Colorado: University of Colorado; 2002:30.
• [47]Lee PN: Mortality from tobacco in developed countries: are indirect estimates reliable? Regul Toxicol Pharmacol 1996, 24:60-68.
• [48]Heinrich J: Estimates of Selected Health Consequences of Cigarette Smoking Were Reasonable. In CDC’s Report On Smoking. Washington: United States General Accounting Office; 2002.
• [49]Thun M, Apicella L, Henley S: Estimating the numbers of smoking- related deaths. JAMA 2000, 284:2319-2320.